![Ming-Kuei Jang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ming-Kuei Jang is the founder of Aprinoia Therapeutics, Inc., founded in 2015, holding the titles of Chairman & Chief Executive Officer and Chairman & President-Asia Operations since 2023.
Dr. Jang is the founder of Suzhou Xinxu Pharmaceutical Co., Ltd., founded in 2017, holding the title of Chairman & President since 2017.
Dr. Jang currently works at APRINOIA Therapeutics LLC as Chief Scientific Officer.
Formerly, Dr. Jang worked at Glaxosmithkline China Ltd. from 2010 to 2012 as Associate Director.
Dr. Jang completed undergraduate studies at National Taiwan University and earned a doctorate from Boston University School of Medicine.
| Sociétés | Poste | Début |
|---|---|---|
Aprinoia Therapeutics, Inc.
 Aprinoia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company targeting neurodegenerative diseases | Directeur Général | 20/05/2015 |
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on neurodegenerative diseases | Fondateur | 01/01/2015 |
APRINOIA Therapeutics LLC | Directeur Technique/Scientifique/R&D | - |
Suzhou Xinxu Pharmaceutical Co. Ltd.
 Suzhou Xinxu Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for neurodegenerative diseases | Fondateur | 01/01/2017 |
| Sociétés | Poste | Fin |
|---|---|---|
Glaxosmithkline China Ltd. | Corporate Officer/Principal | 01/03/2012 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 7 |
|---|---|
National Taiwan University
 National Taiwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glaxosmithkline China Ltd. | |
Boston University School of Medicine
 Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aprinoia Therapeutics, Inc.
Aprinoia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company targeting neurodegenerative diseases | Health Technology |
Suzhou Xinxu Pharmaceutical Co. Ltd.
Suzhou Xinxu Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for neurodegenerative diseases | Health Technology |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on neurodegenerative diseases | Health Technology |
APRINOIA Therapeutics LLC | Electronic Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
